United Therapeutics buy Royal Bank of Canada
Start price
07.05.26
/
50%
€485.40
Target price
07.05.27
€596.27
Performance (%)
-4.22%
Price
08:31
€464.90
Summary
This prediction is currently active. With a performance of -4.22%, the BUY prediction for United Therapeutics by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -0.705% | -0.705% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $707.00 to $701.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€493.50
07.07.26
07.07.26
€615.51
07.07.27
07.07.27
-5.80%
08:31
08:31
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
8.90%
08:31
08:31
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
27.58%
08:31
08:31